The conference will together people with lived and living experience, policymakers, service providers, and health and social care professionals to explore responses to drug-related deaths and harms.
Trimbos Institute hosts a webinar exploring how shifting geopolitical priorities in Europe are reshaping drug policy, public health and harm reduction services.
C-EHRN highlights shifting drug trends across Europe, noting the rising prevalence of polydrug use, potent synthetic substances, and the critical need for adapted harm reduction services.
Harris et al. find that providing inhalation equipment alongside workforce training facilitates stronger relationships between providers and people who use crack, and new engagement opportunities, despite enduring structural barriers.
The Scottish Drugs Forum published a human-centred list of recommendations for the incoming Scottish government, emphasising courageous policymaking and leading with compassion.
Evaluation of Switzerland’s cannabis pilot trials finds high participant satisfaction, no notable public-order incidents, and early signs that legal access models can reduce reliance on the illicit market.
Polanski has called for a public health approach, with responsibly regulated drug markets, arguing that the current system pushes drug use into illegality, fueling risks and violence.
The European Commission’s proposed 2026–2030 EU Drugs Strategy shifts emphasis toward enforcement and border control, prompting calls to prioritise harm reduction, housing, community-based care and rights-based approaches.
INHSU 2026 will convene researchers, practitioners, advocates and people who use drugs in Prague to advance evidence-based approaches to HIV, hepatitis and harm reduction in substance use settings.